These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 11945161)

  • 1. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.
    de Soultrait VR; Lozach PY; Altmeyer R; Tarrago-Litvak L; Litvak S; Andréola ML
    J Mol Biol; 2002 Nov; 324(2):195-203. PubMed ID: 12441099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Computer-aided Antiviral Drug Design Targeting HIV-1 Integrase and Reverse Transcriptase Associated Ribonuclease H.
    Yang F; Yang J; Zhang Z; Tu G; Yao X; Xue W; Zhu F
    Curr Med Chem; 2022; 29(10):1664-1676. PubMed ID: 34238145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments.
    Gill MSA; Hassan SS; Ahemad N
    Eur J Med Chem; 2019 Oct; 179():423-448. PubMed ID: 31265935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase.
    de Soultrait VR; Desjobert C; Tarrago-Litvak L
    Curr Med Chem; 2003 Sep; 10(18):1765-78. PubMed ID: 12871103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 integrase: a target for new AIDS chemotherapeutics.
    Anthony NJ
    Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase.
    Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S
    Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain.
    Cuzzucoli Crucitti G; Métifiot M; Pescatori L; Messore A; Madia VN; Pupo G; Saccoliti F; Scipione L; Tortorella S; Esposito F; Corona A; Cadeddu M; Marchand C; Pommier Y; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2015 Feb; 58(4):1915-28. PubMed ID: 25629256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotides as inhibitors of human immunodeficiency virus.
    Field AK
    Curr Opin Mol Ther; 1999 Jun; 1(3):323-31. PubMed ID: 11713797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
    Gu SX; Xue P; Ju XL; Zhu YY
    Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibitor design for HIV-1 reverse transcriptase and integrase enzymes: a molecular docking study.
    Ercan S; Şenyiğit B; Şenses Y
    J Biomol Struct Dyn; 2020 Feb; 38(2):573-580. PubMed ID: 31787027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: current status and future challenges.
    Kharkwal H; Kumar BK; Murugesan S; Singhvi G; Avasthi P; Goyal A; Jamalis J; Chander S
    Future Med Chem; 2021 Feb; 13(3):269-286. PubMed ID: 33399497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
    Sun L; Gao P; Dong G; Zhang X; Cheng X; Ding X; Wang X; Daelemans D; De Clercq E; Pannecouque C; Menéndez-Arias L; Zhan P; Liu X
    Eur J Med Chem; 2018 Jul; 155():714-724. PubMed ID: 29940462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diketo acids derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
    Di Santo R
    Curr Med Chem; 2011; 18(22):3335-42. PubMed ID: 21728968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV integrase inhibitors as therapeutic agents in AIDS.
    Nair V; Chi G
    Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of peptide motifs against HIV-1 reverse transcriptase and integrase.
    Andréola ML
    Curr Pharm Des; 2009; 15(21):2508-19. PubMed ID: 19601847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.